Literature DB >> 32630241

Percutaneous Electrolysis in the Treatment of Lateral Epicondylalgia: A Single-Blind Randomized Controlled Trial.

Manuel Rodríguez-Huguet1,2, Jorge Góngora-Rodríguez3, Rafael Lomas-Vega4, Rocío Martín-Valero5, Ángeles Díaz-Fernández4, Esteban Obrero-Gaitán4, Alfonso Javier Ibáñez-Vera4, Daniel Rodríguez-Almagro4.   

Abstract

Few studies have considered the effects of percutaneous electrolysis (PE) in the treatment of lateral epicondylalgia (LE). For this reason, the objective of this study was to compare the effects of PE with an evidence-based approach-trigger point dry needling (TDN)-in patients with LE. A randomized controlled trial was conducted in which 32 participants with LE were randomly assigned to two treatment groups, the PE group (n = 16) and the TDN group (n = 16). Both groups received four therapy sessions and an eccentric exercise program to be performed daily. The numerical pain rating scale (NPRS), pressure pain thresholds (PPT), quality of life, and range of motion were measured before treatment, at the end of treatment, and at one- and three-month follow-ups. Significant between-group mean differences were found after treatment for NPRS (p < 0.001) and flexion movement (p = 0.006). At one-month follow-up, significant mean differences between groups were found for NPRS (p < 0.001), PPT (p = 0.021), and flexion (p = 0.036). At three-months follow-up, significant mean differences between groups were found for NPRS (p < 0.001), PPT (p = 0.004), and flexion (p = 0.003). This study provides evidence that PE could be more effective than TDN for short- and medium-term improvement of pain and PPTs in LE when added to an eccentric exercise program.

Entities:  

Keywords:  elbow tendinopathy; electrolysis; lateral epicondylalgia; lateral epicondylitis; physical therapy; tennis elbow

Year:  2020        PMID: 32630241     DOI: 10.3390/jcm9072068

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

1.  Endogenous Pain Modulation in Response to a Single Session of Percutaneous Electrolysis in Healthy Population: A Double-Blinded Randomized Clinical Trial.

Authors:  Sergio Varela-Rodríguez; José Luis Sánchez-Sánchez; Enrique Velasco; Miguel Delicado-Miralles; Juan Luis Sánchez-González
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

2.  Analgesic and Functional Efficiency of High-Voltage Electrical Stimulation in Patients with Lateral Epicondylitis-A Report with a 180-Day Follow-Up.

Authors:  Paweł T Dolibog; Beata Porębska; Sławomir Grzegorczyn; Daria Chmielewska; Andrzej Ślęzak; Patrycja Dolibog
Journal:  J Clin Med       Date:  2022-05-04       Impact factor: 4.964

3.  Cadaveric and Ultrasound Validation of Percutaneous Electrolysis Approaches at the Arcade of Frohse: A Potential Treatment for Radial Tunnel Syndrome.

Authors:  Pedro Belón-Pérez; Laura Calderón-Díez; José Luis Sánchez-Sánchez; Miguel Robles-García; Gustavo Plaza-Manzano; César Fernández-de-Las-Peñas
Journal:  Int J Environ Res Public Health       Date:  2022-02-21       Impact factor: 3.390

Review 4.  The use of respiratory muscle training in patients with pulmonary dysfunction, internal diseases or central nervous system disorders: a systematic review with meta-analysis.

Authors:  Luisa Cacciante; Andrea Turolla; Giorgia Pregnolato; Sara Federico; Francesca Baldan; Anna Rutkowska; Sebastian Rutkowski
Journal:  Qual Life Res       Date:  2022-04-23       Impact factor: 3.440

5.  In vitro bacteriological effect of tri-beveled needle electrolysis against Staphylococcus aureus.

Authors:  José Antonio García-Vidal; Jesús Salinas; Nieves Ortega; Pilar Escolar-Reina; Fabio Camacho-Alonso; Francesc Medina-Mirapeix
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

6.  Cadaveric and Ultrasound Validation of Percutaneous Electrolysis Approach at the Achilles Tendon as a Potential Treatment for Achilles Tendinopathy: A Pilot Study.

Authors:  Laura Calderón-Díez; José Luis Sánchez-Sánchez; Miguel Robles-García; Pedro Belón-Pérez; César Fernández-de-Las-Peñas
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.